BANK OF AMERICA CORP /DE/
BankPosition in SGMOQ — Sangamo Therapeutics, Inc
CIK 70858
CHARLOTTE, NC
Position in SGMOQ
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$459,596
+$420,125 QoQ
Shares Held
1,838,390
+1856.1% QoQ
Ownership
0.444%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Derivatives in SGMOQ
reported options exposure · as of Sep 30, 2021CallValue
$360,400
CallShares
40,000
PutValue
$360,400
PutShares
40,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in SGMOQ
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $459,596 | 1,838,390 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $39,471 | 93,984 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $67,314 | 100,470 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $58,301 | 107,970 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $79,710 | 120,777 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $337,879 | 331,256 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $103,196 | 118,618 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $56,961 | 158,231 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $180,268 | 269,060 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $124,626 | 230,794 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $741,117 | 1,235,198 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $511,857 | 393,738 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,055,204 | 1,167,731 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,496,985 | 1,113,690 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,759,990 | 767,345 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,894,144 | 699,069 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,321,087 | 743,733 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,208,431 | 427,791 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $360,400 | 40,000 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $360,400 | 40,000 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $4,121,712 | 457,460 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,286,287 | 358,086 | Shares | Defined | 2021-09-13 | |
| 2021-06-30 | $1,633,905 | 136,500 | Call | Defined | 2021-09-13 | |
| 2021-03-31 | $3,265,318 | 260,600 | Call | Defined | 2021-05-14 | |
| 2021-03-31 | $375,900 | 30,000 | Put | Defined | 2021-05-14 | |
| 2021-03-31 | $4,458,960 | 355,863 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,817,246 | 308,600 | Call | Defined | 2021-02-10 | |
| 2020-12-31 | $3,951,981 | 253,170 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,704,532 | 286,194 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,178,809 | 243,171 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $570,584 | 89,574 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||